I-Stem and Roche form research collaboration to discover new therapies for diseases such as Alzheimer’s and schizophrenia

I-Stem, the Institute for Stem cell Therapy and Exploration of Monogenic Diseases, has signed an agreement with Swissbased healthcare company Roche to use I-Stem’s technologies in discovering novel therapies to treat devastating central nervous system (CNS) diseases such as Alzheimer’s, schizophrenia, depression and anxiety.

 

<< Return to the section “Press releases”